Top in hem/onc: Bitcoin mining, Cancer Moonshot program
Bitcoin mining, as well as managing other cryptocurrencies, can serve as an ancillary income stream for physicians, according to Sanjeev Bhatia, MD, an orthopedic sports medicine surgeon at Northwestern Medicine.
In his latest Residency to Retirement column, Bhatia discusses a variety of factors that make bitcoin mining profitable. It was the top story in hematology/oncology last week.
Another top story explored President Joe Biden’s goals for the relaunched Cancer Moonshot program, which include cutting cancer deaths by 50% in 25 years.
Read these and more top stories in hematology/oncology below:
Bitcoin mining as an ancillary income stream: A primer for physicians of all ages
Many millennial physicians have known about bitcoin and other cryptocurrencies for years. Read more.
Biden relaunches Moonshot with aim to cut cancer deaths by at least 50% in 25 years
Biden recently relaunched the Cancer Moonshot program, an initiative he spearheaded in 2016 as vice president and one he is reigniting with a goal to “end cancer as we know it.” Read more.
7 important updates for World Cancer Day
Union for International Cancer Control created World Cancer Day in 2000 to educate the public about the signs and symptoms of cancer to ensure early detection and treatment, encourage elected representatives to commit ample resources to reduce cancer mortality, and increase awareness that lifestyle behaviors can have a considerable effect on cancer risk. Read more.
Out-of-spec CAR-T appears safe, effective for younger patients with ALL
B-cell acute lymphoblastic leukemia is the most common type of cancer among children. It also is a contemporary treatment success story, with American Cancer Society data showing a 5-year survival rate of 90%. Read more.
Rural residents more likely to express feelings of cancer fatalism, information overload
Residents of rural areas demonstrated higher levels of cancer fatalism and cancer information overload than urban residents, according to a study in Cancer Epidemiology, Biomarkers & Prevention. Read more.